VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Infanrix-hexa
Vaccine Information
  • Vaccine Name: Infanrix-hexa
  • Target Pathogen: Hepatitis B virus
  • Target Disease: Hepatitis B
  • Product Name: Combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine
  • Tradename: Infanrix-hexa
  • Manufacturer: GlaxoSmithKline
  • Vaccine Ontology ID: VO_0010719
  • Type: Subunit vaccine + Inactivated or "killed" vaccine
  • Status: Licensed
  • Location Licensed: Canada
  • Host Species for Licensed Use: Human
  • Adjuvant:
  • Adjuvant:
  • Preservative: 2 phenoxy ethanol
  • Allergen: Polymyxin B Neomycin, Latex in plunger stopper of prefilled syringe
  • Immunization Route: Intramuscular injection (i.m.)
  • Storage: Should be stored at 2° to 8°C (35° to 46°F).
  • Approved Age for Licensed Use: Under 7 years of age.
  • Description: Products: Proteins + killed viruses + conjugate. Other components: Yeast protein Formaldehyde, Lactose, Polysorbate 20 and 80.
Host Response
References